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Rods and cones have analogous phototransduction components and cycles, but differ from each other in their physiological response to light. 
Differences between the affinities of rod and cone phosphodiesterase (PDE) catalytic subunits for their respective inhibitory subunits could 
potentially contribute to these physiological differences. To test this idea, we expressed both the 13 kDa PDE subunit, unique to a subset of bovine 
retinal cones [(1990) J. Biol. Chem. 265, 11259-I 12641, and the rod PDE 11 kDa inhibitory subunit in E. coli, purified them, and compared their 
abilities to inhibit rod and cone PDE catalytic subunits. Rod PDE has similar K, values (-80 PM) for both the rod and cone recombinant inhibitory 
subunits. Activated cone PDE has K, values of 200 pM for the cone 13 kDa subunit and 600 pM for rod PDEy. 
Retinal phosphodiesterase; Inhibition; Cyclic GMP; Bovine retina 
1. INTRODUCTION 
In the outer segments of vertebrate rod photorecep- 
tors, cGMP phosphodiesterase (PDE) hydrolyzes 
cGMP in response to light [l]. This causes cation chan- 
nels in the outer segments to close, and the cell to hyper- 
polarize [2]. The phototransduction cascade begins 
when light-activated rhodopsin binds transducin 
(TaJ?y), enabling it to exchange its bound GDP for GTP 
[3]. Tel-GTP dissociates from T/?y [4] and activates the 
PDE. Whether Ta-GTP actually binds and removes the 
PDE inhibitory subunits [5] or whether it binds and 
remains associated with the PDE [6,7] is still a matter 
of controversy. Within seconds of PDE activation, TOZ 
hydrolyzes GTP to GDP [8] and dissociates from the 
PDE, allowing PDEy to recombine with PDEaj?. An 
analogous cascade exists in cones. Thus PDEy has two 
main interactions in photoreceptors, one with Ta and 
one with the PDE catalytic subunits. It is this latter 
interaction which we explore in this study. 
dimer is associated with at least two 11 kDa inhibitory 
(y) subunits [5]. This holoenzyme can be activated by 
trypsin which selectively degrades the PDEy subunits 
[l,lO]. A more soluble form of rod PDE also exists. It 
is similar to the membrane-associated form except that 
it co-purifies with a 15 kDa protein which is also present 
in preparations of cone PDE [ 111. The catalytic complex 
of cone PDE is a homodimer of a’ (94 kDa) subunits. 
Two smaller subunits (11 and 13 kDa) purify with the 
cone PDE catalytic subunit. The 11 kDa subunit may 
be rod PDEy that co-purifies with cone PDE [12]; how- 
ever, the 13 kDa subunit is unique to cones [2,11]. Puri- 
fied cone PDE exhibits higher basal activity and is acti- 
vated by lower concentrations of rod transducin than 
the rod PDE isozyme [l 11. 
The catalytic complex of the membrane-associated 
bovine rod PDE consists of a homo- or heterodimer of 
CI (88 kDa) and jI (84 kDa) subunits [1,9]. The catalytic 
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Components of the rod phototransduction cascade 
can be readily isolated from bovine retina since rods are 
more abundant than cones. Cones have unique forms 
of opsin [ 131, transducin [ 14,151 and phosphodiesterase 
[12,16], and differ greatly from rods in their response to 
light. A rod cell can respond to a single photon; cones 
require lOO-fold more photons to achieve the same sig- 
nal [17]. Cones are quick to respond, quick to recover 
[18] and can adapt over a far wider range of light inten- 
sities than can rods [ 171. Here we explore the hypothesis 
that differences in the interaction between rod and cone 
PDEs and their respective inhibitory subunits may ac- 
count in part for these physiological differences. 
Abbrevrations: cGMP, guanosine 3’,5’-cyclic monophosphate; HPLC, 
high pressure liquid chromatography; PAGE, polyacrylamide gel elec- 
trophoresis; PDE, phosphodiesterase; PMSF, phenylmethylsulfonyl 
fluoride; SDS, sodium dodecyl sulfate. 
2. MATERIALS AND METHODS 
2.1. Maferials 
[8-‘H]cGMP and [U-?]GMP were obtained from Amersham ([U- 
‘%Z]GMP is currently unavailable). Factor Xa, aprotinin, leupeptin, 
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bestatin, and pepstatin were ordered from Boehrmger-Mannheim. 
Trypsin, soybean trypsin inhibitor. PMSF, and benzamidine came 
from Sigma. Aquapore RP-300 Brownlee columns came from Rainm. 
2.2. PurlJication of rod and cone PDE holoenzymes 
Rod and cone PDE holoenzymes were purified as described by 
Gillespie and Beavo [ll] and Gillespie et al. [19]. Concentrations of
these PDEs were determined by Bradford assay and were multiplied 
by a factor of 0.8 to yield concentrations consistent with amino acid 
analyses [19]. 
2.3. Expression and purlficatlon of recombinant proteins 
The bovine 11 kDa and cone PDE 13 kDa Inhibitory subunits were 
expressed using a method reported by Brown and Stryer [20]. Each 
subunit is expressed as a ilcII N-terminal fusion with a Factor Xa 
protease cleavage site between the two proteins. Treatment with Fac- 
tor Xa generates a protein with the native amino acid sequence. The 
plasmid containing the /IcII-Factor Xa-Rod PDEy fusion cDNA 
(pLcIIFXSG) was a generous gift of L. Brown and L. Stryer (Stanford 
University, Stanford, CA) and was used to express the rod PDEy 
described here. The bovine cone 13 kDa PDEy construct was made 
by PCR amplification of clone 14-6 [12] using primers that added 
appropriate restriction enzyme sites. The Factor Xacone 13 kDa 
PDEy construct replaced the Factor Xa-rod PDEy in pLcIIFXSG 
and was sequenced to avoid PCR artifacts. 
The plasmids described above were transformed into E colt AR68 
cells (gift of L. Brown and L. Stryer) before each expression experi- 
ment, Methods for expression and crude protem purification are de- 
scribed m Brown and Stryer [20]. All buffers contamed 10 pug/ml 
leupeptin, 1 &/ml aprotinin, 10 ,@ml pepstatm. 1 mM benzamidme, 
2 mM PMSF, and 3 pg/ml bestatin. Fusion protein was quanotated 
by the Bradford method, digested with Factor Xa. and isolated by 
reverse-phase HPLC using an Aquapore RP-300 Brownlee column 
and conditions described m Brown and Stryer [20]. Fractions contain- 
mg PDEy were identified using an antibody (PDE B) raised agamst 
the basic mid-region (amino acids 2445 m rod PDEy) common to 
both rod 11 kDa and cone 13 kDa PDEy’s. These fractions were dried 
in siliconized microfuge tubes and dissolved in 30 ~1 distilled water. 
Rod PDEy co-eluted with a 9 kDa degradative product. Additional 
protease inhibitors and cell lysis by boiling or somcatton failed to 
prevent degradation. To purify the non-degraded form. the rod PDEy 
was extracted from an 18% preparative mini-SDS-gel slice (2-3 mm) 
by the method of Wensel and Stryer (Fig. 9 in [7]). A preparative 
SDS-gel loaded with water was treated similarly for control purposes. 
Cone 13 kDa PDEy showed little degradation but was SDS-PAGE- 
purified for purposes of comparison. 
Protein concentrations in gel extracts were routinely determined by 
Bradford assay. BSA standards were spiked with a volume of control 
gel extract to control for any bias introduced by SDS-PAGE compo- 
nents. Concentrations were more accurately determined by amino acid 
analysis of duplicate aliquots. Concentrations determined by Bradford 
assay were corrected by multiplying by a factor of 0.54 for 11 kDa 
PDEy and 0.73 for 13 kDa PDEr. 
2.4. PDE assays 
PDE assays follow the [‘H]cGMP protocol of Gillespie [21], al- 
though final assay volumes were 0.1 ml. Maximally activated PDE was 
produced by treatment with trypsin for 7 min on ice followed by the 
addition of 6X trypsin inhibitor. 
In experiments determining the amount of active subumt, activities 
were assayed using 1 nM trypsin-activated rod PDE and 20 mM 
cGMP. In assays estimating K, values, the final PDE concentration 
was 1 pM and the cGMP concentration was 5 PM. Results were 
corrected for 14C recovery and blanks were subtracted. 
3. RESULTS AND DISCUSSION 
Recombinant rod I1 kDa and cone 13 kDa PDE 
subunits were expressed in E. coli and purified in order 
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Fig. 1. An SDS-PAGE gel (15% acrylamide/O.lb% bis-acrylamide) 
stained with Coomassie blue showing purified bovine cone and (solu- 
ble) rod PDEs in the outer lanes, and recombinant cone 13 kDa and 
rod 1 I kDa PDE subunits in the inner lanes. Equal amounts (0.1 pug) 
of the 11 and 13 kDa PDEy’s were loaded. A 2-fold excess of cone 
PDE (3.5 pug) compared to rod PDE (1.8 pg) was loaded to show the 
band at 13 kDa in cone PDE. 
to compare their abilities to inhibit photoreceptor PDE 
catalytic subunits. Both subunits were expressed as 
dcII-PDEy fusion proteins by a previously described 
method [20]. The cI1 fragment was cleaved from the 
N-terminus of each PDEy-fusion product by Factor 
Xa. Expressed PDEy subunits were extracted with urea 
and purified using a CM-Sephadex C-50 column fol- 
lowed by reverse-phase HPLC. Both rod and cone 
PDEy’s were further purified by SDS-PAGE and their 
concentrations determined by amino acid analysis. An 
SDS gel stained with Coomassie blue (Fig. 1) shows the 
purified recombinant PDEy subunits and the cone and 
soluble rod PDE holoenzymes. 
3.1. Activity of expressed PDEy subunits 
The activity of each purified subunit was determined 
by titrating against purified trypsin-activated rod PDE. 
The concentration of activated PDE used in these exper- 
iments was verified by measuring average specific activ- 
ity. 1,830 + 250 ~mollminlmg (five experiments, each in 
triplicate), which falls between published values ranging 
from 1,200-l ,500 ~mollminlmg [IO] to 2,300 pmol/min/ 
mg 1111. 
To estimate the percent of active PDEy in our prepa- 
rations. the amount needed to fully inhibit 1 nM tryp- 
sin-activated rod PDE was determined. At this concen- 
tration (well above the believed K, of interaction), the 
relationship between inhibition of PDE activity and 
concentration of PDEy should remain linear until the 
concentration of free catalytic subunits approaches the 
K,. The concentration of PDEy needed for 100% inhibi- 
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tion was determined by extrapolating the linear portion 
of the titration curve to 0% activity. The validity of this 
approach was confirmed by computing inhibition 
curves expected for 1 nM total PDE exhibiting theoret- 
ical K, values of 800 pM, 80 pM, and 8 pM for PDEy 
(Fig. 2, inset). At least two inhibitory subunits are be- 
lieved necessary for full inhibition of rod PDE [5], so 
x-intercept values were divided by two to determine the 
concentration of active PDEy. The number of inhib- 
itory subunits needed to fully inhibit the cone PDE has 
not been reported. We have assumed that two are neces- 
sary. 
Fig. 2 is an example of titration results from a repre- 
sentative experiment using trypsin-activated rod PDE 
and bacterially expressed rod PDEy (solid circles). Ex- 
trapolation of the data shown in Fig. 2 suggests that 4 
nM rod PDEy completely inhibited 1 nM PDE catalytic 
complex. If this inhibitory subunit were fully active and 
the stoichiometry of PDEy subunits per PDE catalytic 
complex is 2: 1, a value of 2 nM would have been ob- 
tained. Since complete inhibition requires a 2-fold 
higher concentration of rod PDEy than predicted, only 
---T-e- 
IRod x nM1 
Fig. 2. Titration of trypsin-activated soluble rod PDE with recombi- 
nant rod 11 kDa PDEy (0). Error bars represent the SD. of triplicate 
analyses. Complete inhibition was extrapolated to a total rod PDEy 
concentration of 4 nM. Assuming two inhibitory subunits per holoen- 
zyme. inhibition of the 1 nM PDE used in the experiment should be 
complete at 2 nM of fully active rod PDEy. Since a 2-fold higher 
concentration of rod PDEy is required than predicted, the SDS-gel- 
purified inhibitor is -50% active. Trypsin treatment of this rod PDEy 
followed by addition of trypsin inhibitor destroyed all inhibitory activ- 
tty (0). (Inset) Theoretical inhibition curves computed for 1 nM total 
PDE. Curves were calculated by an iterative procedure using the 
formula K, = {[P](l,-P,+[P])}l(P,-[pl) and three hypothetical K, val- 
ues (800 pM, 80 pM, 8 PM) for interaction between PDE and PDEy. 
An estimate of the concentration of active inhibitor can be determined 
by extrapolating the linear portion of the curve where the concentra- 
tion of free PDE is greater than K,. (P = free PDE, P, = total PDE, 
I, = total PDEy.) 
%--T-T- -7 
Log [Inhibitory Subunit, M] Log [Inhibitory Subunit. Ml 
Fig. 3. Inhibition curves of trypsin-activated rod and cone PDEs (1 
PM) with recombinant rod and cone PDE inhibitory subunits. Error 
bars represent S.E.M. calculated from three experiments, each done 
in triplicate. (a) K, values of 79 pM and 83 pM are shown for inhibition 
of activated rod PDE with recombinant rod and cone PDE inhibitory 
subunits, respectively. (b) K, values of 200 pM and 600 pM are shown 
for inhibition of activated cone PDE with recombinant cone 13 kDa 
PDEy and rod PDEy. respectively. 
50% of the rod PDEy appears to be active. To prove 
that the inhibition observed is due to PDEy, an aliquot 
of rod PDEy was digested with trypsin; the results 
(open squares) show that trypsin destroys the inhibi- 
tion. The activity of the SDS-PAGE-purified PDEy was 
stable for several weeks, but was only 9% active after 
6 months. Identical dilutions and volumes of extracted 
control gel added to activated rod PDE showed no inhi- 
bition (data not shown). 
The concentration of cone 13 kDa PDEy required for 
100% inhibition was 3.7 t 0.5 nM (n = 3; data not 
shown). Thus, 34-fold higher concentrations were re- 
quired than predicted, indicating that the purified cone 
PDEy was 27% active, on average. Trypsin also de- 
stroyed the inhibitory properties of the 13 kDa PDEy. 
3.2. K, values for the inhibitory subunits 
Inhibition constants for inhibition of trypsin-acti- 
vated rod and cone PDE catalytic subunits by rod and 
cone inhibitory subunits were compared at a catalytic 
subunit concentration (1 PM) at which IC,, values 
should approximate the K,. Increasing concentrations 
of inhibitory subunits were added to activated PDE and 
equilibrated on ice for 15-30 min before assaying. Re- 
sults of these experiments are presented in Fig. 3. 
Activated rod PDE exhibited virtually identical K, 
values for the recombinant rod PDEy (79 PM) and 
recombinant cone 13 kDa PDEy (83 pM, Fig. 3a). K, 
values for the interaction of activated cone PDE with 
recombinant cone 13 kDa PDEy and rod PDEy were 
200 pM and 600 pM (Fig. 3b), respectively. Similar 
experiments were conducted using rod and cone PDE 
inhibitory subunits purified from bovine retinas [21]. 
159 
Volume 318, number 2 FEBSLETTERS March 1993 
-13 -11 -9 -7 
Log (Inhibitory Subunit, M] 
Fig. 4. Hill plots for interactions between trypsm-activated rod PDE 
and its inhibitor (0) and trypsin-activated cone PDE and the cone 13 
kDa PDEy (0). using the purified recombinant mhibitory subunits. 
Slopes are approximately 1.1, indicating that inhibitor binding is not 
cooperative. 
The affinities of trypsin-activated rod PDE for retinal 
rod and cone inhibitory subunits was 6 pM and 48 pM, 
respectively. Cone PDE showed affinities of 23 pM and 
91 pM for retinal rod and cone inhibitory subunits [21]. 
The lower affinities obtained with the recombinant 
proteins may reflect a structural difference between ret- 
inal vs. bacterially expressed PDEy subunits. For in- 
stance, the N-terminus of rod PDEy is reported to be 
acetylated [22]. Perhaps such a modification is necessary 
to achieve optimal interactions or protein folding. In 
addition, the 13 kDa subunit isolated from bovine reti- 
nal cone PDE may contain a mixture of red/green and 
blue cone PDEy subunits which may co-elute during 
isolation by HPLC and co-migrate on SDS-PAGE. In 
contrast, the recombinant 13 kDa protein is strictly spe- 
cific to a subset of cones [12]. The titers of purified 
recombinant subunits are higher than those for isolated 
retinal PDEy’s (-12% active) [23]. The recombinant 
PDEy’s also appear to be more stable. The inhibitors 
isolated from bovine retina lose 40-75% of their inhib- 
itory activity over a two week period [23]. These differ- 
ences may account for the range of K, values. The large 
quantities of stable recombinant PDEy subunits make 
them preferable for use in future phototransduction 
studies. 
Regardless of whether retinal or recombinant PDEy 
is used, rod PDE has a higher affinity for PDE inhib- 
itory subunits than does cone PDE. If PDE K, values 
were the only factor determining physiological differ- 
ences between rod and cone responses, we might actu- 
ally expect rod PDE to have a weaker affinity for inhib- 
itory subunits since they are IOO-fold more sensitive to 
light. The concentration of PDE in rod photoreceptors 
is -30 PM [24]. Assuming this value is similar in cones 
and that conditions of steady state are attained, the 
concentration of PDEy in vivo is far above any of the 
observed K, values. The differences we observe within 
the picomolar range may therefore be of little conse- 
quence within the cell. However, absolute rates of 
PDEy association and dissociation could play a role in 
response variations. Alternatively, there may be a mech- 
anism which decreases the effective concentration of 
PDEy available for inhibiting the catalytic subunits; for 
instance, bovine rod PDEy can be phosphorylated in 
vitro [25]. 
Wensel and Stryer [6] examined the effects of dilution 
on the activity of native PDE in ROS homogenates and 
purified PDE in solution. They estimated that the disso- 
ciation constant for the rod inhibitor from the catalytic 
complex is less than 10 pM. This number falls at the low 
end of our K, range, perhaps because our catalytic sub- 
units were modified by trypsin digestion. Trypsin is 
known to nick the $3 complex of rod PDE [26] and the 
01’ subunit of cone PDE [23], removing a small C-termi- 
nal fragment from these proteins. 
3.3. Cooprrativity 
We used Hill plots [27] to examine our data for evi- 
dence of cooperative interaction between the PDE cata- 
lytic and inhibitory subunits. At concentrations of PDE 
below the presumed K, of interaction with PDEy, ‘sites 
occupied’ (Q) is analogous to percent PDE inhibited 
and ‘sites vacant’ (1-Q) is represented by percent PDE 
uninhibited. Fig. 4 is a Hill plot for the inhibition of rod 
and cone PDEs with recombinant rod 11 kDa and cone 
13 kDa PDE subunits. The mid-portions of both plots 
yield slopes of 1 .l, indicating that the binding of the 
second PDEy is most probably independent of the bind- 
ing of the first. 
Interactions of PDEy’s with molecules other than the 
PDE catalytic subunits could contribute to differences 
between rod vs. cone responses. For example, Gillespie 
and Beavo [ 1 l] reported that a 50-fold higher concentra- 
tion of rod TCX was required for half-maximal stimula- 
tion of rod PDE vs. cone PDE. In addition, purified 
cone PDE has a higher basal activity than rod PDE [ 111. 
These properties could arise from the lower affinity of 
cone PDE catalytic subunits for the inhibitory subunits. 
The recombinant PDEy subunits may now be used to 
explore (a) the rates of dissociation within the PDE 
holoenzymes and (b) the interactions of the PDE inhib- 
itory subunits with transducins. 
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